Se­r­i­al start­up sci­en­tist Ronald Evans tests a new Mighty Mouse drug, mak­ing marathon run­ners with a pill

Salk In­sti­tute’s leg­endary sci­en­tist Ronald Evans has co-found­ed a string of new biotech com­pa­nies over the years, in­clud­ing Lig­and Phar­ma­ceu­ti­cals, Syn­dax and more re­cent­ly San Diego-based Metacrine. And now he’s com­plet­ed new pre­clin­i­cal re­search on a drug that he says has at­tract­ed at­ten­tion from some oth­er com­pa­nies in the bio­phar­ma world in­ter­est­ed in try­ing it on hu­mans.

And this one is a doozie.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER